Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-02-24 @ 8:50 AM
Study NCT ID:
NCT02389959
Status:
COMPLETED
Last Update Posted:
2021-09-01
First Post:
2015-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intranasal Bevacizumab for HHT-Related Epistaxis
Sponsor:
Stanford University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
29501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None